Washington, D.C. 20549
|X| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
Indicate by check mark if the registrant is
a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes |_| No | X |
Indicate by check mark if the registrant is
not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes |_| No |X|
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes |_| No |X|
Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files). Yes |_| No |X|
Indicate by check mark if disclosure of delinquent
filers pursuant to Item 405 of Regulation S-K (ss. 229.405 of this chapter) is not contained herein, and will not be contained,
to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference
in Part III of this Form 10-K or any amendment to this Form 10-K | X |
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of
"large accelerated filer," "accelerated filer," and "smaller reporting company" in Rule 12b-2 of
the Exchange Act. (Check one):
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Act). Yes |X| No |_|
State the aggregate market value of the voting
and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold,
or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed
second fiscal quarter. As of December 31, 2013, the aggregate market value of the common stock of the registrant held by non-affiliates
(excluding shares held by directors, officers and others holding more than 5% of the outstanding shares of the class) was $261,920,
based upon the most recent sale price of $0.004.
Indicate the number of shares outstanding
of each of the registrant's classes of common stock, as of the latest practicable date. As of June 2, 2014, the registrant
had outstanding 195,480,000 shares of Common Stock.
This annual report contains
forward-looking statements which involve assumptions and describe our future plans,, strategies and expectations, are generally
identifiable by us of the words “may,” “will,” “should,” “expect,” "anticipate,"
"estimate," "believe," "intend" or "project" or the negative of these words or other
variations on these words or comparable terminology. These statements are expressed in good faith and based upon a reasonable
basis when made, but there can be no assurance that these expectations will be achieved or accomplished.
Such forward-looking statements
include statements regarding, among other things, (i) our potential profitability and cash flows, (ii)
our growth and acquisition strategies, (iii) our future financing plans and (iv) our anticipated
needs for working capital. This information may involve known and unknown risks, uncertainties, and other factors that
may cause our actual results, performance, or achievements to be materially different from the future results, performance, or
achievements expressed or implied by any forward-looking statements. These statements may be found under “Management's
Plan of Operation" and "Description of Our Business and Properties," as well as in this annual report generally.
Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors,
including, without limitation, the risks outlined under "Risk Factors" and matters described in this annual report generally.
In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this report
will in fact occur.
Although forward-looking statements
in this annual report reflect the good faith judgment of our management, forward-looking statements are
inherently subject to known and unknown risks, business, economic and other risks and uncertainties that may
cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged
not to place undue reliance on these forward-looking statements, which speak only as of the date of this annual report. We
assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after
the date of this annual report, other than as may be required by applicable law or regulation. Readers are urged to carefully
review and consider the various disclosures made by us in this annual report which attempt to advise interested parties of the
risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more
of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially
from those expected or projected. We will have little likelihood of long-term success unless we are able to raise capital
from the sale of our securities until, if ever, we generate positive cash flow from operations.
PART I
ITEM 1. DESCRIPTION OF BUSINESS
Modern Mobility Aids, Inc. (“the Company”,
“we’, “us” or “our”) was formed on December 19, 2007. Our previous business plan had been to
import and sell scooters, power chairs, walkers, wheelchairs and other mobility products to the Russian market. We did not manufacture
the products we offered for sale but acquired our products from third-party manufactures. On September 2, 2009, we incorporated
a wholly owned subsidiary Modern Mobility Aids, Inc. (Canada). On July 14, 2011, we incorporated a wholly owned subsidiary, MDRM
Group (Canada) Ltd.
References in this report to “Modern
Mobility Aids” refer to Modern Mobility Aids, Inc. and its subsidiaries, on a consolidated basis, unless otherwise indicated
or the context otherwise requires.
Our Business
Description of Business
Until May 2011, Modern Mobility Aids had been
a wholesaler/distributor of mobility products such as scooters, power chairs, wheelchairs, walkers and canes in the Russian market.
We initially planned to import, market and sell a range of mobility products to the Russian market to be used by mobility challenged
individuals to achieve a greater level of independence from their caretakers. Users of mobility products include the elderly, individuals
with paralysis, arthritis, weakness, coronary or lung issues and obesity.
We did not manufacture the products we offered
for sale. Historically, we focused our efforts on establishing relationships with local distributors in Russia in order to sell
our products. We signed a broker agreement with OOO Elite Moto, a company based in Moscow, Russia. OOO Elite Moto represented our
products in the Moskovskaya Oblast’ region, which includes Moscow and the surrounding suburbs. Our agreement obligated us
to pay OOO Elite Moto a 5% commission calculated on the gross invoice received. We sold $9,506 worth of products since signing
the contract on April 26, 2010.
We abandoned our historic business which generated
little operating revenue and had limited operations. Our Board of Directors has determined that the Company will seek to acquire
business assets or stock in companies that either have existing operations or are in the development stage with the potential for
successful operations. We will require financing to make such acquisitions. There can be no assurance we can secure such financing
or that we will be able to make such acquisitions even if financing is available. Moreover, even if we acquire business assets
or a business, there can be no assurance that the acquisitions will be successfully accomplished or that our operations thereafter
will be profitable.
Competition
We have no continuing operations and therefore
do not face any competition. We will face competition with respect to any new business we initiate.
Bankruptcy or Similar Proceedings
There have been no bankruptcy, receivership
or similar proceedings.
Reorganizations, Purchase or Sale of Assets
There have been no material reclassifications,
mergers, consolidations, or purchase or sale of a significant amount of assets not in the ordinary course of business.
Compliance with Government Regulation
We will be required to comply with any government
regulations which apply to any new business we initiate.
Patents, Trademarks, Franchises, Concessions,
Royalty Agreements, or Labor Contracts
We have no current plans for any registrations
such as patents, trademarks, copyrights, franchises, concessions, royalty agreements or labor contracts.
Need for Government Approval for its Products
or Services
We have no continuing business operations at
the present time and are not required to apply for or have any government approvals for products or services at this time. We may
be required to do so if we initiate business operations.
Research and Development Costs during the
Last Two Years
We have not expended funds for research and
development costs since inception.
Employees and Employment Agreements
We have no employees and three officers. They
will devote as much time as is necessary to manage the affairs of the company. There are no formal employment agreements between
the company and any employee.
Change of Control
On May 26, 2011 (the “Closing Date”),
a change of control of the Company occurred. Pursuant to two Stock Purchase Agreements (the “SPAs”), Sergei Khorolski,
formerly the
President, Chief Executive Officer
and a Director of the Company and Valeri Politika,
formerly the
Chief Financial Officer, Secretary, Treasurer
and a Director of the Company,
sold a total of 6,500,000 shares (pre-split) of common stock of the Company (the “Transactions”) to Mohamed K. Karatella.
The total consideration paid for the shares purchased pursuant to the SPAs was $65,000, [which was paid from Mr. Karatella’s
own funds.] Pursuant to the SPAs, Mr. Karatella acquired an aggregate of approximately 66.5% of the outstanding voting common stock
of the Registrant.
In connection with the Transactions, under
the terms of the SPAs, Sergei Khorolski and Valeri Politika, who were the only members of our Board of Directors prior to the Transactions
appointed Mohamed K. Karatella and Antonio Domingues to serve as members of our Board of Directors. Furthermore, Mr. Khorolski
and Mr. Politika resigned as members of our Board of Directors on May 27, 2011. In addition, on the Closing Date, Mr. Khorolski
and Mr. Politika resigned as officers of the Company. On that date, Mohamed K. Karatella was appointed our President, Chief Financial
Officer, and Treasurer and Antonio Domingues our Secretary. Due to the sale of our common stock pursuant to the SPAs and the change
in the composition of our Board of Directors, there was a change of control of our Company at both the stockholder and director
levels.
In April, 2012, Mohamed K. Karatella resigned
as a member of our Board of Directors and as an officer of the Company and of its subsidiaries. Also, in April, 2012, Ferman A.
Naqvi and Darshna Tanna, who had been elected to our Board of Directors, resigned as members of the Board of Directors of the Company
and of its subsidiaries. On the same day, Antonio Domingues was appointed our and our subsidiaries’ President, Chief Financial
Officer, Treasurer and Secretary and as a member of the board of directors of our subsidiaries.
Since April 2012, we had several changes in
the composition of our Board of Directors and executive officers. We filed a current report on Form 8-K, disclosing certain of
these changes on March 11, 2014, reflecting the appointments of Declan French and Preston J. Shea as members of the Board of Directors.
Since that date, Sam Hill and Declan French resigned and our Board of Directors appointed Kenneth Pinckard as a member of our Board
of Directors and as our Chief Executive Officer. The current members of our Board of Directors are: Mr. Kenneth Pinckard, who also
serves as our Chief Executive Officer and Mr. Preston J. Shea, who also serves as our President, Chief Financial Officer, Treasurer
and Secretary.
Mr. Pinckard, Mr. French and Mr. Shea have
no family relationships with any executive officer or director of the Company or persons nominated or chosen by the Company to
become directors or officers. There is no arrangement or understanding pursuant to which any of them was appointed a member of
the Board of Directors nor is the Company aware of any transaction requiring disclosure under Item 404(a) of Regulation S-K with
respect to Mr. Pinckard.
The Company has abandoned its historic business
which has generated little operating revenue and has had limited operations to date. Our Board of Directors has determined that
the Company will seek to acquire business assets or stock in companies that either have existing operations or are in the development
stage with the potential for successful operations. We will require financing to make such acquisitions. There can be no assurance
we can secure such financing or that we will be able to make such acquisitions even if financing is available. Moreover, even if
we acquire business assets or a business, there can be no assurance that the acquisitions will be successfully accomplished or
that our operations thereafter will be profitable.
Memorandums of Understanding
On March 28, 2014, through a wholly-owned subsidiary
incorporated under the laws of Ontario, Canada, we entered into a Memorandum of Understanding to purchase 67% of a private company
with a pending application for a license from Health Canada under the recently enacted Marijuana for Medical Purposes Regulation
(“MMPR”). The facilities are located in the Province of Ontario. In addition, the agreement provides that we will also
acquire a 50% interest in a related private corporation which has received a “ready to build” letter from Health Canada
in conjunction with a pending application for a license to conduct research on marijuana. The closing of this transaction is contingent
on the issuance of the respective licenses by Health Canada.
On May 8, 2014, through a wholly-owned subsidiary
formed in Ontario, Canada, we entered into an agreement to purchase 100% of a private company in the final stage of obtaining their
Medical Marijuana growers license. The company, located in the Province of Ontario, owns a fully functional production facility,
and is awaiting final inspection by Health Canada. The transaction includes real property and related facilities.
Under the terms of the agreement, the company
will pay CDN$2.5 million at Closing with an additional CDN$2.5 million due at a deferred date. The company will also issue a warrant to the sellers to
purchase up to 1 million shares of the Company shares at a 25% discount to market. The closing of the purchase is subject to receipt
of a license from Health Canada under MMPR.
The Company is actively and aggressively pursuing
various other opportunities relating to the medical marijuana and biopharma industries which meet its investment criteria. To this
end, we have entered into letters of intent to purchase controlling interests in two other private companies each in the final
stages of obtaining their Medical Marijuana growers license. The actual terms and conditions of these two proposed transactions
will be disclosed at such time as the Company has entered into definitive agreements on the matters.
Amendments to Articles of Incorporation
or Bylaws; Change in Fiscal Year
On August 12, 2011, we filed an amendment to
our Certificate of Incorporation to increase the number of shares that the Company is authorized to issue from 70,000,000 shares
of common stock to 200,000,000 shares of common stock, $0.001 par value per share, and to authorize the issuance of 1,000,000 shares
of preferred stock, $0.001 par value per share (the “Increased Authorization”). The amendment was approved by our Board
of Directors and by Mohamed K. Karatella, who owns approximately 66.5% of our issued and outstanding common stock. The major reason
that we increased our authorization of common stock was to have sufficient shares of common stock available to effect a 20 for
1 forward split of our common stock outstanding.
The amendment to our Certificate of Incorporation
also authorizes the Company to issue 1,000,000 shares of preferred stock. Preferred stock can be issued, without shareholder consent,
by our Board of
Directors as it shall determine from time to time, in one or more series, with special
voting rights, designations, preferences or other special rights, and qualifications, limitations or restrictions, as the board
my determine, including, without limitation, dividend rights, conversion rights, redemption privileges and liquidation preferences.
Any future issuance of preferred stock may have the effect of delaying, deferring or preventing a change in control of the Company
without further action by the Company’s shareholders and may adversely affect the voting and other rights of the voters of
common stock.
Stock Split
In August, 2011, we effected a 20 for 1 forward
split of our shares of common stock outstanding. All owners of record at the close of business on August 23, 2011 (the record
date) received 19 additional shares of common stock for every one share they owned on such date.
Future Redemption
Mohamed K. Karatella, formerly the Company’s
President, Chief Financial Officer, Treasurer, Principal Accounting Officer and the owner of 66.5% of its outstanding common stock
has agreed to contribute 120,000,000 shares of the Company’s common stock to the Company to be cancelled. Mr. Karatella will
not receive any compensation in connection with this transfer. After the transaction, Mr. Karatella will own 10,000,000, 13.25%,
of 75,480,000 shares of common stock of the Company then outstanding.
Reports to Securities Holders
We are subject to disclosure filing requirements,
including filing Form 10-K annually and Forms 10-Q quarterly. We filed our last quarterly report for the quarter ended March 31,
2013 on May 20, 2013. Since that date, due to the lack of funds, we have defaulted on our filing requirements. We intend to file
all delinquent reports as soon as we are able to do so. The public may read and copy any materials that we file with the Securities
and Exchange Commission, ("SEC"), at the SEC's Public Reference Room at 100 F Street NE, Washington, DC 20549. The public
may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an
Internet site (http://www.sec.gov) that contains reports, information statements, and other information regarding issuers that
file electronically with the SEC.
ITEM 1A. RISK FACTORS
You should carefully consider the risks
described below and other information contained in this report before making a decision to acquire shares of our common stock.
Any of the events discussed in the risk factors below may occur. If they do, our business, results of operations or financial condition
could be materially adversely affected.
We have been mainly dependent upon
the funds provided to us by our shareholders who are not obligated to provide us the funds necessary for us to continue as a going
concern.
We are a startup company and we have no
operations. We will need additional funds to initiate any business or to acquire a business or any assets we wish to acquire
.
There is no assurance that any additional financing will be available, or if available, on terms that will be acceptable
to us. If we are not able to obtain needed financing, we may have to cease operations. Even if we raise the funds necessary
to acquire a business, there can be no assurance that such business will be successful or that we will be able to continue as a
going concern.
Any industry in which the Company operates will likely be
highly competitive and the Company’s competitors may be larger and may have greater financial resources than the Company
does.
Given our limited resources and limited business
experience we will likely face strong competition with respect to any business we engage in from competitors which will have greater
experience and have substantially more resources then we have
. The strong competition that we will face
may have a material adverse effect on our business.
The company is subject to certain risks in our international
operations
We expect that most of our sales will initially be generated outside
the United States of America. Accordingly, we will be subject to a number of risks, any of which could harm our business, relating
to doing business internationally, including:
1. Exchange controls and currency exchange rates;
2. Inflation;
3. Political and economic issues in foreign countries;
4. Foreign tax treaties and policies;
5. Restrictions on the transfer
of funds to and from foreign countries; and
6. General economic conditions where end users of the
company’s products reside.
Fluctuations in foreign currency exchange rates could harm
our results of operations.
We expect to conduct business outside the U.S.
As a result, we will be exposed to gains and losses resulting from the effect of fluctuations in foreign currency exchange rates.
Currency exchange rates are subject to fluctuation due to, among other things, changes in local, regional or global economic conditions,
the imposition of currency exchange restrictions and unexpected changes in regulatory or taxation environments. Significant fluctuations
in foreign currency exchange rates may adversely affect any business in which we are engaged.
We lack an operating history and have
losses which we expect to continue into the future. There is no assurance our future operations will result in profitable
revenues. If we cannot generate sufficient revenues to operate profitably, our business will fail.
We were incorporated on December 19, 2007,
have realized $9,506 in revenues and incurred $585,040 in losses since inception. We have very little operating history upon
which an evaluation of our future success or failure can be made. This is particularly true due to our abandonment of the
business we previously operated and changes in our Board of Directors and executive officers. Any revenues we do generate may not
be sufficient to cover our operating costs. We cannot guarantee that we will be successful in generating significant revenues
in the future. Failure to achieve a sustainable sales level will cause us to cease all operations.
There is substantial uncertainty as to
whether we will continue operations.
Our registered independent auditors have discussed
their uncertainty regarding our business operations in their audit report for the year ended June 30, 2013. This means that
there is substantial doubt that we can continue as an ongoing concern for the next 12 months. The financial statements do
not include any adjustments that might result from the uncertainty about our ability to continue in business. As such, we
may have to cease operations and you could lose your entire investment.
We depend on key personnel.
Our future success will depend in large
part on the continued service of our executive officers. We have not entered into an employment agreement
with any of them. If any of our executive officers choose to leave the company we will face significant difficulties in attracting
a potential replacement candidates due to our limited financial resources and operating history.
Our officers and directors are not obligated to commit their
time and attention exclusively to our business and therefore they may encounter conflicts of interest with respect to the allocation
of time and business opportunities between our operations and those of other businesses.
Our officers and directors are not obligated
to commit their time and attention exclusively to our business and, accordingly, they may encounter conflicts of interest in allocating
their own time, or any business opportunities which they may encounter, between our operations and those of other businesses.
Currently, our executive officers are under
no obligation to commit any time to us, and their failure to do so may adversely affect our ability to continue as a going concern.
Additionally, officers and directors, in the
course of their other business activities, may become aware of investment, business or information which may be appropriate for
presentation to us as well as to other entities to which he owes a fiduciary duty or in which he is involved. They may also in
the future become affiliated with entities that are engaged in business or other activities similar to those we intend to conduct.
As a result, they may have conflicts of interest in determining to which entity particular opportunities or information should
be presented. If, as a result of such conflict, we are deprived of investment, business or information, our ability to initiate
any business may be adversely affected.
We do not intend to pay dividends.
We have never paid any cash dividends and currently
do not intend to pay any dividends for the foreseeable future. Furthermore, we require additional funding and our funding
sources may prohibit the payment of dividends. Because we do not intend to declare dividends, any gain on an investment in
Modern Mobility Aids will need to come through appreciation of the price of our common stock.
Holders of our common stock may have
limited recourse against us and since two of our three directors and executive officers reside outside the United States.
Two of our three directors
and executive officers reside outside the United States and the non-United States resident officers and directors assets are located
outside the United States. As a result, holders of our common stock may be limited in their ability to effect service of process
within the United States upon our non-United States resident directors and executive officers or to enforce in a U.S. court
a judgment obtained against them in jurisdictions outside the United States, including actions under the civil liability provisions
of U.S. securities laws. In addition, it may be difficult for holders of our common stock to enforce, in original actions
brought in courts in jurisdictions outside the United States, liabilities predicated upon U.S. securities laws.
Because our majority shareholder owns
66.5% of our outstanding common stock, he can make and control corporate decisions that may be disadvantageous to other minority
shareholders.
Mr. Karatella owns 66.5% our outstanding common
stock at the present time. Accordingly, he will have a significant influence in determining the outcome of all corporate
transactions or other matters, including mergers, consolidations, acquisitions and the sale of all or substantially all of our
assets. He will also have the power to prevent or cause a change in control. His interests may differ from the interests
of the other stockholders and thus result in corporate decisions that are disadvantageous to other shareholders.
The requirements of being a public company have and will continue
to strain our resources, divert management’s attention and affect our ability to attract and retain qualified board members.
As a public company, we are subject to certain
reporting requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Sarbanes-Oxley
Act and other applicable securities rules and regulations. Compliance with these rules and regulations will increase our legal
and financial compliance costs, make some activities more difficult, time-consuming or costly and increase demand on our systems
and resources. The Exchange Act requires, among other things, that we file annual, quarterly
and current reports with respect to our business and financial condition. The Sarbanes-Oxley Act requires, among other things,
that we maintain effective disclosure controls and procedures and internal control over financial reporting. In order to maintain
and, if required, improve our disclosure controls and procedures and internal control over financial reporting to meet this standard,
significant resources and management oversight may be required. As a result, management’s attention may be diverted from
other business concerns, which could have a material adverse effect on our business, financial condition and results of operations.
In addition, changing laws, regulations and
standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing legal
and financial compliance costs and making some activities more time consuming. These laws, regulations and standards are subject
to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may
evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding
compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We may not be able
to invest the resources necessary to comply with evolving laws, regulations and standards, which may result in increased general
and administrative expenses and a diversion of management’s time and attention from revenue-generating activities to compliance
activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory
or governing bodies due to ambiguities related to practice, regulatory authorities may initiate legal proceedings against us and
our business may be harmed.
We also expect that being a public company
and complying with the rules and regulations related thereto will make it more expensive for us to obtain director and officer
liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage.
We do not have director and officer liability insurance at this time. These factors could also make it more difficult for us to
attract and retain qualified members of our Board of Directors and qualified executive officers.
There is a limited public (trading) market
for our common stock and there is no assurance that our common stock will ever be actively traded; therefore, our investors may
not be able to sell their shares.
Our common stock is listed on the OTC
Markets, Pink Sheets, and trading has generally been very limited. We can provide no assurance that an active market for our common
stock will ever develop. When it does trade, our shares are often traded at less than $0.01 per share. As a result, stockholders
may be unable to liquidate their investments, or may encounter considerable delay in selling shares of our common stock.
An active trading market may not develop in the future, and if one does develop, it may not be sustained. If an active
trading market does develop, the market price of our common stock is
likely to be highly
volatile due to, among other things, because we are a relatively new public company with a limited operating
history. Further, even if a more active public market develops, the volume of trading in our common stock will presumably
be limited and likely be dominated by a few individual stockholders. The limited volume, if any, will make the price of our
common stock subject to manipulation by one or more stockholders and will significantly limit the number of shares that one can
purchase or sell in a short period of time. The market price of our common stock may also fluctuate significantly in response
to the following factors, most of which are beyond our control:
|
-
|
variations in our quarterly operating results, if any;
|
|
-
|
changes in general economic conditions;
|
|
-
|
announcements by us or our competitors of significant new
|
|
|
contracts, acquisitions,
strategic partnerships or joint ventures, or capital commitments; and
|
|
-
|
the addition or loss of key managerial and collaborative personnel.
|
The equity markets have, on occasion,
experienced significant price and volume fluctuations that have affected the market prices for many companies' securities
and that have often been unrelated to the operating performance of these companies.
Any such fluctuations may adversely affect the market price of our common stock, regardless of our actual operating performance.
As a result, stockholders may be unable to sell their shares, or may be forced to sell them at a loss.
You could be diluted due to our
future issuance of capital stock and derivative securities.
As of May 20, 2014, we had 195,480,000
shares of common stock outstanding and no shares of preferred stock outstanding. We are authorized to issue up to 200,000,000
shares of common stock and 1,000,000 shares of preferred stock. To the extent of such authorization, our Board
of Directors will have the ability, without seeking stockholder approval, to issue additional shares of common
stock or preferred stock in the future for such consideration as the Board
of Directors may consider sufficient. The issuance of additional common stock or preferred stock in the future may
reduce your proportionate ownership and voting power. Also, any shares of preferred stock the Company issues may have preferences
as compared to our common stock and reduce the likelihood of a change of control of the Company in the future.
A lack of internal control over
financial reporting has, and could result in the future, in an inability to adequately and timely report our financial results,
which could lead to a loss of investor confidence in our financial reports and have an adverse effect on our stock price.
Effective internal controls are necessary
for use to provide reliable and timely financial reports. We have been unable to provide timely financial reports due to a lack
of financial resources necessary to retain qualified individuals with the relevant accounting experience. Our management has concluded
that we had a material weakness in our internal controls over financial reporting.
A failure to maintain effective internal
control over financial reporting could result in a material misstatement of our financial statements or otherwise cause us to fail
to meet our financial reporting obligations. This, in turn, could result in a loss of investor confidence in the accuracy and completeness
of our financial reports, which could have an adverse effect on our business, financial condition, operating results and our stock
price, and we could be subject to stockholder litigation and the costs associated therewith.
Our common stock is classified as a “Penny
Stock” as that term is generally defined in the Securities Exchange Act of 1934 to mean equity securities with a price of
less than $5.00. Our common stock will be subject to rules that impose sales practice and disclosure requirements on broker-dealers
who engage in certain transactions involving a Penny Stock.
The SEC has adopted regulations which generally
define so-called "penny stocks" to be an equity security that has a market price less than $5.00 per share or an exercise
price of less than $5.00 per share, subject to certain exemptions. As of June 2,
2014, the closing sale price of our
common stock was less than $1.00] per share and, therefore, it is designated a "penny stock." As a "penny
stock," our Common Stock likely is subject to Rule 15g-9 under the Exchange Act of 1934, or the "Penny Stock
Rule." This rule imposes additional sales practice requirements on broker-dealers that sell such securities to persons
other than established customers and "accredited investors" (generally, individuals with a net worth in excess of
$1,000,000 or annual incomes exceeding $200,000, or $300,000 together with their spouses).
For any transaction involving a penny stock,
unless exempt, the penny stock rules require that a broker or dealer approve a person's account for transactions in penny stocks
and the broker or dealer receive from the investor a written agreement to the transaction setting forth the identity and quantity
of the penny stock to be purchased. In order to approve a person's account for transactions in penny stocks, the broker or
dealer must obtain financial information and investment experience and objectives of the person and make a reasonable determination
that the transactions in penny stocks are suitable for that person and that that person has sufficient knowledge and experience
in financial matters to be capable of evaluating the risks of transactions in penny stocks.
The broker or dealer must also deliver, prior
to any transaction in a penny stock, a disclosure schedule prepared by the SEC relating to the penny stock market, which, in highlight
form, sets forth:
The basis on which the broker or dealer made
the suitability determination, and that the broker or dealer received a signed, written agreement from the investor prior to the
transaction.
Disclosure also has to be made about the risks
of investing in penny stocks in both public offerings and in secondary trading and commissions payable to both the broker-dealer
and the registered representative, current quotations for the securities and the rights and remedies available to an investor in
cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information
for the penny stock held in the account and information on the limited market in penny stocks.
Because of these regulations, broker-dealers
may not wish to engage in the above-referenced necessary paperwork and disclosures and/or may encounter difficulties in their attempt
to sell shares of our Common Stock, which may affect the ability of selling shareholders or other holders to sell their shares
in any secondary market and have the effect of reducing the level of trading activity in any secondary market. These additional
sales practice and disclosure requirements could impede the sale of our Common Stock. In addition, the liquidity for our Common
Stock may decrease, with a corresponding decrease in the price of our Common Stock. Our Common Stock, in all probability, will
be subject to such penny stock rules for the foreseeable future and our shareholders will, in all likelihood, find it difficult
to sell their common stock.
There can be no assurance that our Common Stock
will qualify for exemption from the Penny Stock Rule. In any event, even if our Common Stock were exempt from the Penny Stock Rule,
we would remain subject to Section 15(b) (6) of the Exchange Act, which gives the SEC the authority to restrict any person from
participating in a distribution of a penny stock if the SEC determines that such a restriction would be in the public interest.
You may face significant restrictions on the resale of your
shares due to state “blue sky” laws.
Each state has its own securities laws, often
called “blue sky” laws, which (1) limit sales of securities to a state’s residents unless the securities are registered in that state or qualify for an
exemption from registration, and (2) govern the reporting requirements for broker-dealers doing business directly or indirectly
in the state. Before a security is sold in a state, there must be a registration in place to cover the transaction, or it must
be exempt from registration. The applicable broker-dealer must also be registered in that state.
We do not know whether our securities will
be registered or exempt from registration under the laws of any state. A determination regarding registration will be made by those
broker-dealers, if any, who agree to serve as market makers for our common stock. There may be significant state blue sky law restrictions
on the ability of investors to sell, and on purchasers to buy, our securities. You should therefore consider the resale market
for our common stock to be limited, as you may be unable to resell your shares without the significant expense of state registration
or qualification.
ITEM 2. PROPERTIES
We do not currently
own any property.
We are currently operating out of offices at One Canadian Place, Suite 350, Toronto, Ontario M5X 1C1.
Management believes the current premises are sufficient for its needs at this time.
ITEM 3. LEGAL PROCEEDINGS
We are not currently involved in any legal
proceedings nor do we have any knowledge of any threatened litigation.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
PART II
ITEM 5. MARKET FOR COMMON EQUITY AND RELATED
STOCKHOLDER MATTERS
Market Information
Our common stock is currently listed for traded
on the OTC-Pink Sheets under the symbol “MDRM”. While there has been sporadic trading activity, there has generally
been no active trading market. Our common stock has typically traded below $0.01 per share.
The following table sets forth the range of
high and low bid quotations for each fiscal quarter for the last two fiscal years. These quotations reflect inter-dealer
prices without retail mark-up, markdown, or commissions and may not necessarily represent actual transactions.
For the Fiscal Year Ending on June 30, 2013
|
|
High
|
|
|
Low
|
|
Quarter Ended June 30, 2013
|
|
$
|
0.01
|
|
|
$
|
0.00
|
|
Quarter Ended March 31, 2013
|
|
|
0.01
|
|
|
|
0.00
|
|
Quarter Ended December 31, 2012
|
|
|
0.01
|
|
|
|
0.00
|
|
Quarter Ended September 30, 2012
|
|
|
0.01
|
|
|
|
0.00
|
|
For the Fiscal Year Ending on June 30, 2012
|
|
High
|
|
|
Low
|
|
Quarter Ended June 30, 2012
|
|
$
|
0.03
|
|
|
$
|
0.00
|
|
Quarter Ended March 31, 2012
|
|
|
0.07
|
|
|
|
0.02
|
|
Quarter Ended December 31, 2011
|
|
|
0.42
|
|
|
|
0.02
|
|
Quarter Ended September 30, 2011
|
|
|
1.90
|
|
|
|
0.08
|
|
For the period from June 30, 2013 through December 31, 2013,
the high and low bid quotations for our stock remained about the same without much fluctuation or volume. Beginning in February,
2014 and continuing to the date of this filing, the bid quotations have ranged from a high of $0.19 and a low of $0.00 for the
Quarter Ended March 31, 2014, and for the subsequent period to the date of this filing, a high of $0.20 and a low of $0.09, with
an average daily trading volume of 1,198,371 for the past 90 days.
Of the 195,480,000 shares of common stock outstanding
as of June 30, 2013, 130,000,000 shares are owned by Mohamed Karatella, and may only be resold in compliance with Rule 144 of the
Securities Act of 1933. Mr. Karatella has agreed to transfer 120,000,000 shares of the Company’s common stock to the Company
at an agreed price of $19,043 to be cancelled.
As of June 2, 2014, we had 195,480,000
Shares of $0.001 par value common stock issued and outstanding held by
12
shareholders of record.
The stock transfer agent for our securities
is Island Stock Transfer, Inc.
Dividends
We have never declared or paid any cash dividends
on our common stock. For the foreseeable future, we intend to retain any earnings to finance the development and expansion of any
business we acquire, and we do not anticipate paying any cash dividends on our common stock. Any future determination to pay dividends
will be at the discretion of the Board of Directors and will be dependent upon then existing conditions, including our financial
condition and results of operations, capital requirements, contractual restrictions, business prospects, and other factors that
the board of directors considers relevant.
Because our common stock is considered
a “penny stock”, a shareholder may have difficulty selling shares in the secondary trading market.
Our common stock is subject to certain rules
and regulations relating to "penny stock" (generally defined as any equity security that has a price less than $5.00
per share, subject to certain exemptions). Broker-dealers who sell penny stocks are subject to certain "sales practice requirements"
for sales in certain nonexempt transactions (i.e., sales to persons other than established customers and institutional "accredited
investors"), including requiring delivery of a risk disclosure document relating to the penny stock market and monthly statements
disclosing recent price information for the penny stocks held in the account, and certain other restrictions. For as long as our
common stock is subject to the rules on penny stocks, the market liquidity for such securities could be significantly limited.
This lack of liquidity may also make it more difficult for us to raise capital in the future through sales of equity in the public
or private markets.
Securities authorized for issuance under
equity compensation plans
We do not have any equity compensation plans
and accordingly we have no securities authorized for issuance thereunder.
Section 16(a)
Because we do not have any securities registered
under the Securities Exchange Act of 1934, our executive officer, principal shareholder and members of our Board of Directors
are generally not required to file reports required by Section 16(a) of the Securities Exchange Act of 1934.
ITEM 6. SELECTED FINANCIAL DATA
Since we are a smaller operating company, this
item is not applicable to us.
ITEM 7. MANAGEMENT’S DISCUSSION
AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERTIONS
Forward-Looking Statements and Associated Risks.
The following discussion should be read
in conjunction with the financial statements and the notes to those statements included elsewhere in this Annual Report on Form 10-K.
This Annual Report on Form 10-K contains certain statements that are forward-looking within the meaning of the Private Securities
Litigation Reform Act of 1995. Certain statements contained in the MD&A are forward-looking statements that involve risks and
uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates,
assumptions and projections about our industry, business and future financial results. Our actual results could differ materially
from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in other
sections of this Annual Report on Form 10-K.
We have generated revenues of $9,506 since
inception and have incurred $597,160 in expenses through June 30, 2013.
The following table provides selected financial
data about our company for the years ended June 30, 2013 and 2012.
Balance Sheet Data:
|
|
|
06/30/13
|
|
|
|
06/30/12
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
0
|
|
|
$
|
0
|
|
Total assets
|
|
$
|
0
|
|
|
$
|
0
|
|
Total liabilities
|
|
$
|
519,773
|
|
|
$
|
467,171
|
|
Shareholders' equity
|
|
$
|
(519,773
|
)
|
|
$
|
(467,171
|
)
|
Cash provided by financing activities for the
year ended June 30, 2013 was $58,771. Cash provided by financing activities since inception was $430,194, $47,425 from the sale
of shares, $17,842 was contributed by a related party, $4,360 was loaned to us by a related party and $360,567 was loaned to us
by our shareholders.
Plan of Operation
The following discussion and analysis should
be read in conjunction with our financial statements and notes thereto included elsewhere in this Form 10-K. Except for the historical
information contained herein, the discussion in this Form 10-K contains certain forward-looking statements that involve risks and
uncertainties, such as statements of our plans, objectives, expectations and intentions. The cautionary statements made in this
Form 10-K should be read as being applicable to all related forward-looking statements wherever they appear in this Form 10-K.
The Company's actual results could differ materially from those discussed here.
Modern Mobility Aids, Inc. (the “Company”)
is a Nevada corporation in the development stage and has no active business. The Company was incorporated under the laws of the State of Nevada
on December 19, 2007 under the name Glider Inc. The Company
changed its name to Modern Mobility
Aids, Inc. on April 22, 2010.
References in this Report to “Modern
Mobility Aids” refer to Modern Mobility Aids Inc. and its subsidiaries, on a consolidated basis, unless otherwise indicated
or the context otherwise requires. The Company's consolidated financial statements for the twelve months ended June 30, 2013, and
2012, include the accounts of its wholly owned subsidiary Modern Mobility Aids, Inc., and MDRFM Group (Canada) Ltd., both
Ontario, Canada, based companies.
The Company to date has funded its initial
operations through the issuance of shares of capital stock for net proceeds of $47,425, revenue from sales of $9,506, $17,842 from
contributions by a related party, $4,360 by loan to us by a related party and $360,567 by loan to us by our shareholders.
Due to the uncertainty of our ability to generate
sufficient revenues from our operating activities and/or to obtain the necessary financing to meet our obligations and repay our
liabilities arising from normal operations when they come due, in their report on our financial statements for the years ended
June 30, 2013 and 2012, our registered independent auditors included additional comments indicating concerns about our ability
to continue as a going concern. Our financial statements contain additional note disclosures describing the circumstances that
led to this disclosure by our registered independent auditors. The financial statements do not include any adjustments that might
result from the outcome of this uncertainty.
Our cash balance at June 30, 2013 is $0. We
expect to experience a shortage of funds. From time to time, our shareholders have been lending us funds to enable us to pay our
operating expenses. They did not lend us the funds necessary to allow us to timely file this annual report or our subsequent quarterly
reports. There are no formal binding commitments or binding arrangements with any person to advance or loan us funds. There are
no terms regarding repayment of any loans or capital contributions. If our shareholders do not advance us the funds necessary to
enable us to pay our expenses, we will not be able to continue.
The Company has abandoned its historic business
which has generated little operating revenue and has had limited operations to date. Our Board of Directors has determined that
the Company will seek to acquire business assets or stock in companies that either have existing operations or are in the development
stage with the potential for successful operations. We will require financing to make such acquisitions. There can be no assurance
we can secure such financing or that we will be able to make such acquisitions even if financing is available. Moreover, even if
we acquire business assets or a business, there can be no assurance that the acquisitions will be successfully accomplished and
that our operations thereafter will be profitable.
Results of Operations
For the year ended June 30, 2013 compared to year ended June
30, 2012
Revenue
During the years ended June 30, 2013 and 2012
we generated $0 in revenues from sales.
Operating Expenses
During the year ended June 30, 2013, we incurred
$55,216 compared to $363,619 in the twelve months ended June 30, 2012. During the twelve months ended June 30, 2013 we incurred
$12,750 for general administrative and accounting fees; $13,082 for consulting fees, $22,509 in legal fees, $6,795 for transfer
agent fees and $80 in other miscellaneous expenses. Comparison, during the twelve months ended June 30, 2012 we incurred $6,700
for general administrative and accounting fees; $226,335 for consulting fees, $60,149 in legal fees, $38,205 legal fees –
organization costs, $14,979 for transfer agent fees, $16,757 in interest expense and other miscellaneous charges, and $494 in bank
charges.
Operating expenses for the year ended June 30, 2013 declined by
some $291,500 compared with the previous year. This decline is primarily attributable to reduced consulting, legal and professional
fees. During the year ended June 30, 2012, $226,000 in consulting fees were paid in connection with the proposed acquisition of
Lumigene Technologies, and for investor relations, compliance and filing fees. In the year under review, June 30, 2013, these services
were not required and therefore the amount declined significantly to $13,000. In addition, in the year ended June 30, 2012, legal
fees totaling $98,000 were paid in connection with the Lumigene matter and for review of financials and preparation and filing
of required reports with the SEC. In the year ended June 30, 2012, such fees were only $22,500 due to a decline in reporting and
compliance activity and the absence of a pending acquisition by the company.
Losses
During the year ended June 30, 2013 we incurred
$52,602 in losses compared with $63,619 in losses during the year ended June 30, 2012 due to the factors discussed above.
Liquidity and Capital Resources
We have incurred $587,654 in operating losses
since inception. As of June 30, 2013 and 2012, we had $0 in cash and liabilities of $519,773 and $467,171 respectively. As
of June 30, 2013, we had a working capital deficiency of $(519,773), compared to a working capital deficiency of $(467,171) as
of June 30, 2012.
Operating activities
Net cash used in operating activities for the
year ended June 30, 2013 was $58,771, compared with net cash used of $242,410 for the prior year period. The majority
of the decrease in net cash used was due to a decrease in operating losses due to lower operating expenses.
Investing Activities
No cash was used in investing activities during
the year ended June 30, 2013 and 2012.
Financing Activities
Net cash provided by financing activities for
the year ended June 30, 2013 was $58,771, and primarily consisted of proceeds of loans from shareholders as compared to net cash
provided by financing activities for the twelve months ended June 30, 2012 which was $242,228, including 241,186 in shareholder
loans.
The Company must raise additional funds to
initiate or acquire a business and to fund our continued operations. We may not be successful in our efforts to raise
additional funds or achieve profitable operations. Even if we are able to raise additional funds through the sale of our securities
or through the issuance of debt securities, or loans from our shareholders or financial institutions, our cash needs could be greater
than anticipated in which case we could be forced to raise additional capital.
At the present time, we have no commitments
for any additional financing, and there can be no assurance that, if needed, additional capital will be available to us on commercially
acceptable terms or at all. These conditions raise substantial doubt as to our ability to continue as a going concern, which may
make it more difficult for us to raise additional capital when needed. If we cannot get the needed capital, we may not be able
to become profitable and may have to curtail or cease our operations.
Recent Accounting Pronouncements
Management
does not believe that any recently issued, but not yet effective, accounting standards, if adopted, will have a material effect
on our financial statements.
Off Balance Sheet Arrangements
We have no off-balance sheet arrangements with
any party.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY
DATA.
The financial information required by this item is set forth beginning
on page F-1 and is incorporated herein by reference.
Item 9. Changes In and
Disagreements with Accountants and Financial Disclosure
(
a)
On November 30, 2013, the RONALD R. CHADWICK, P.C. (“RRC”) the Company’s independent certified public accountants
resigned due to the retirement of the accountant who performed virtually all of the services to the Company.
The report of RRC on the Company’s financial
statements for its fiscal years ended June 30, 2012 and 2011 indicated conditions which raised substantial doubt about the Company’s
ability to continue as a going concern. Except as set forth in the preceding sentence, the report of RRC on the Company’s
financial statements for its fiscal years ended June 30, 2010 and 2011 did not contain an adverse opinion or a disclaimer of opinion
nor was it qualified or modified as to uncertainty, audit scope, or accounting principles. During the Company’s fiscal years
ended June 30, 2010 and 2011 and the subsequent interim periods preceding the termination, there were no disagreements with RRC
on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement,
if not resolved to the satisfaction of RRC would have caused RRC to make reference to the subject matter of the disagreements in
connection with its report on the financial statements for such years or subsequent interim periods.
The Company requested that RRC furnish it with a letter addressed
to the Securities and Exchange Commission (“SEC”) stating whether or not it agrees with the Company’s statements
in this Item 4.01. A copy of the letter furnished by RRC in response to that request, dated March 10, 2014, is filed as Exhibit
16.1 to this Form 8-K.
(b) Effective February 26th 2014, Cutler & Co., LLC (“Cutler”),
was engaged as the Company’s new independent certified accounting firm. During the two most recent fiscal years and the interim
period preceding the engagement of Cutler, the Company has not consulted with Cutler regarding either: (i) the application of accounting
principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the
Company’s financial statements; or (ii) any matter that was either the subject of a disagreement or event identified in paragraph
(a)(1)(iv) of Item 304 of Regulation S-K. The decision to retain Cutler was approved by the Board of Directors of the Company.
We have had no disagreements with either RRC
or Cutler with respect to financial disclosure.
Item
9A. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this
Annual Report on Form 10-K, our management evaluated, with the participation of our principal executive officer and principal financial
officer, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities
Exchange Act of 1934). Based upon that evaluation, our principal executive officer and principal financial officer concluded that,
because of the material weakness described below, our disclosure controls and procedures are not effective in ensuring that information
required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed,
summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and
is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as
appropriate to allow timely decisions regarding required disclosure. Notwithstanding the material weakness described below, our
management, including our principal executive officer and principal financial officer, has concluded that the consolidated financial
statements included in this Annual Report on Form 10-K present fairly, in all material respects, our financial position, results
of operations and cash flows for the periods presented in conformity with GAAP.
Additionally, there were no significant changes
in our internal controls or in other factors that could significantly affect these controls subsequent to the evaluation date.
We have not identified any significant deficiencies or material weaknesses in our internal controls, and therefore there were no
corrective actions taken.
Item
9A(T). Controls and Procedures
Management’s Annual Report on Internal
Control Over Financial Reporting
Management’s Report on Internal Control
over Financial Reporting
Our management is responsible for establishing
and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Securities
Exchange Act of 1934). Our internal control over financial reporting is designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and
includes those policies and procedures that:
•
|
|
pertain to the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of our assets;
|
•
|
|
provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance
with authorizations of our management and directors; and
|
•
|
|
provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use or disposition of our assets that could have a material effect on our financial statements.
|
As of the end of the period covered by this
Annual Report on Form 10-K, our management evaluated, with the participation of our principal executive officer and principal financial officer, the effectiveness
of our internal control over financial reporting. This evaluation was conducted using the framework in Internal Control —
Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based upon that evaluation,
our management concluded that our internal control over financial reporting was not effective as of June 30, 2013, because there
was a material weakness in our internal control over financial reporting. A material weakness is a deficiency, or a combination
of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement
of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. Specifically,
through that evaluation, our management identified a material weakness in our internal control over financial reporting as a result
of (i) inadequate personnel for documenting and execution of processes related to accounting for transactions; (ii) inadequate
segregation of duties due to the lack of qualified accounting department personnel; and (iii) a lack of experienced personnel with
relevant accounting experience, due to our limited financial resources. These deficiencies have resulted in, among other things,
at times us being unable to provide timely account reconciliations. In order to address these issues, we will need to hire qualified
employees or retain qualified individuals with the relevant accounting experience. We have to date been unable to implement remediation
actions due to the lack of financial resources to do so. Our management intends to implement policies and procedures to remediate
the material weakness the Company’s control over financial reporting when it has the financial resources to do so. Our remediation
efforts to address this material weakness will include, among other things, hiring additional qualified personnel and evaluating
or undertaking certain improvements to our systems and processes, which, if successful, we believe will be sufficient to provide
us with the ability to remediate or cure this material weakness in the future. If this material weakness is not remediated or cured,
then this deficiency in internal control over financial reporting could continue to adversely affect the timing and accuracy of
our financial reporting.
The foregoing report
shall not be deemed to be filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that
section.
This annual report does not include an attestation
report of the company's registered public accounting firm regarding internal control over financial reporting. Management's report
was not subject to attestation by the company's registered public accounting firm pursuant to rules of the Securities and Exchange
Commission that permit the company to provide only management's report in this annual report.
Limitations on the Effectiveness of Internal
Control
An internal control system, no matter how well
conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.
Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls
must be considered relative to their costs. Because of the inherent limitations on all internal control systems, no evaluation
of controls can provide absolute assurance that all control issues and instances of fraud, if any, will be detected. These inherent
limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple
error or mistake. The design of any system of internal control is also based in part upon certain assumptions about the likelihood
of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future
conditions. Over time, controls may become inadequate because of changes in circumstances, and/or the degree of compliance with
the policies and procedures may deteriorate. Because
of the inherent limitations in a cost effective internal control system, financial reporting misstatements due to error or fraud
may occur and may not be detected on a timely basis.
Item 9B. Other Information
None.
PART III
Item
10. Directors, Executive Officers and Corporate Governance
The executive officers and directors of Modern Mobility Aids, Inc.,
are:
Name & Address
|
Age
|
Position
|
|
|
|
Kenneth Pinckard
|
68
|
Chief Executive Officer
|
One Canadian Place, Suite 350
|
|
and Director
|
Toronto, Ontario M5X 1C1
|
|
|
|
|
|
Preston J. Shea
|
67
|
President, Chief Financial Officer,
|
One Canadian Place, Suite 350
|
|
Treasurer, Secretary Director
|
Toronto, Ontario M5X 1C1
|
|
and Director
|
Directors are elected to serve until the next
annual meeting of stockholders and until their successors have been elected and qualified. Officers are appointed to serve until
the meeting of the Board of Directors following the next annual meeting of stockholders and until their successors have been elected
and qualified.
Our executive officers expect to devote such
time as they deem necessary to manage the affairs of the company.
No executive officer or director of the corporation
has been the subject of any order, judgment, or decree of any court of competent jurisdiction, or any regulatory agency permanently
or temporarily enjoining, barring, suspending or otherwise limiting him or her from acting as an investment advisor, underwriter,
broker or dealer in the securities industry, or as an affiliated person, director or employee of an investment company, bank, savings
and loan association, or insurance company or from engaging in or continuing any conduct or practice in connection with any such
activity or in connection with the purchase or sale of any securities.
No executive officer or director of the corporation
has been convicted in any criminal proceeding (excluding traffic violations) or is the subject of a criminal proceeding which is
currently pending.
Kenneth Pinckard has served as a
Director of the Company and our Chief Executive Officer since April 2014. He is a member of the State Bar of Arizona with
extensive experience in startup ventures, investments, corporate acquisitions and mergers, turn-arounds and reorganizations,
corporate finance, tax, bankruptcy matters, and commercial real estate development, construction, management and leasing. He
previously practiced law at Chamberlain Hrdlicka White Johnson & Williams in Houston, Texas, as well as having worked in
Coopers & Lybrand’s tax department. Additionally, he also served as in-house legal counsel for Congressman Barry
Goldwater and Hormel Foods heir and music composer, Geordie Hormel. Mr. Pinckard holds a B.B.A., Accounting from the
University of Texas at Austin and a Juris Doctorate from the University of Houston.
Preston J. Shea has served as a member of our
Board of Directors and as our President since February 2014 and as our Chief Executive Officer, Treasurer and Secretary since May,
2014. Mr. Shea is a member of the E-World Board of Directors, Mr. Shea has decades of expertise in the areas of business law and
government regulations. Mr. Shea currently serves as a Senior Vice President of Sakha Enterprises Corp. Prior to this, Mr. Shea
was the President and Secretary of Studio One Media and also served as its Chief Executive Officer. Mr. Shea practiced international
immigration law and business law in Ontario, Canada, Detroit, Michigan and Phoenix, Arizona, with an emphasis on the North American
Free Trade Agreement. Prior to that, he was employed by the government of Canada in various positions including Chief of Staff
for the Federal Minister of the Environment, Special Assistant to the Federal Minister of International Trade, and as a Senior
Investment Advisor in the Los Angeles offices of the Canadian Consulate. Mr. Shea is licensed as an Attorney in the State of Arizona
and as a Barrister and Solicitor by the Law Society of Upper Canada in Ontario. He holds B.A., M.B.A. and an L.L.B.
Significant Employees
As of the date hereof, the Company has no significant employees.
INFORMATION CONCERNING THE BOARD OF DIRECTORS, BOARD COMMITTEES
AND CORPORATE GOVERNANCE
BOARD COMPOSITION
Our Board of Directors currently consists of
three (3) directors. The Company is not a listed issuer whose securities are listed on a national securities exchange, or an inter-dealer
quotation system which has requirements that a majority of the board of directors be independent. Presently we are not required
to comply with the director independence requirements of any national securities exchange. Prior to having our securities
listed on any national securities exchange, we would appoint directors that meet the independence requirements of the applicable
exchange.
COMMITTEES OF THE BOARD
Since the Company's Common Stock is quoted
on the OTC-Pink Sheets, the Board has no immediate plans or need to establish an audit committee with a financial expert or a compensation
committee to determine guidelines for determining the compensation of its executive officers or directors. For similar reasons,
the Company has not adopted a written policy for considering recommendations from stockholders for candidates to serve as directors
or with respect to communications from stockholders.
BOARD MEETINGS AND STOCKHOLDER COMMUNICATIONS
The Board conducted all of its business and
approved all corporate actions during the fiscal year ended June 30, 2013 by the unanimous written consent of its member, in the
absence of formal board meetings. Holders of the Company’s securities can send communications to the board via
mail or telephone to the President at the Company’s principal executive offices. The Company has not yet established
a policy with respect to Board members’ attendance at the annual meetings. A stockholder who wishes to communicate
with our board of directors may do so by directing a written request addressed to our President at the address appearing on the
first page of this Information Statement.
Family Relationships
None.
Conflicts of Interest
We are not aware of any current conflicts of
interest between our officers and directors, and us. However, certain potential conflicts of interests may arise in
the future.
From time to time, one or more of our affiliates
may form or hold an ownership interest in and/or manage other businesses both related and unrelated to the type of business that
we own and operate or may own and operate in the future. These persons may continue to form, hold an ownership interest in and/or
manage additional other businesses which may compete with ours with respect to operations, including financing and marketing, management
time and services and potential customers. These activities may give rise to conflicts between or among our interests and other
businesses with which our affiliates are associated. Our affiliates are in no way prohibited from undertaking such activities,
and neither we nor our stockholders will have any right to require participation in such other activities.
Further, because we may transact business with
some of our officers, directors and other affiliates, as well as with firms in which some of our officers, directors or other affiliates
have a material interest, potential conflicts may arise between the respective interests of us and these related persons or entities.
We believe that such transactions will be effected on terms at least as favorable to us as those available from unrelated third
parties.
Term of Office
Our directors are elected for a one-year term.
Our officers are appointed by our Board of Directors and hold office until removed by the board. All officers and directors
listed below will remain in office until their successors have been duly elected and qualified. There are no agreements with respect
to the election of directors.
Compliance With Section 16(A) Of The Exchange
Act.
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING
COMPLIANCE
Since we do not have any capital stock registered
under the Securities Exchange Act of 1934, as amended, the Company’s directors and executive officers, and persons who beneficially
own more than 10 percent of a registered class of the Company’s equity securities, are not required to file reports of beneficial
ownership and changes in beneficial ownership of the Company’s securities with the SEC on Forms 3 (initial Statement of Beneficial
Ownership), 4 (Statement of Changes of Beneficial Ownership of Securities) and 5 (Annual Statement of Beneficial Ownership Securities).
CODE OF ETHICS
The Company has not adopted a written
code of ethics that applies to the Company's principal executive officer, principal financial officer, principal accounting
officer and any persons performing similar functions. The Company expects to adopt a Code of Ethics in the future.
ITEM 11. COMPENSATION OF EXECUTIVE OFFICERS
AND DIRECTORS
The following table shows for fiscal years
ended June 30, 2014 and 2013, respectively, certain compensation awarded or paid to, or earned by, our current and former President,
Chief Executive Officer and Chief Financial Officer.
None of our executive officers earned more
than $100,000 in salary and bonus for the 2013 or 2012 fiscal years. We did not grant options to acquire shares of our Common Stock
to them during the period indicated.
SUMMARY COMPENSATION TABLE
NAME AND
PRINCIPAL
|
|
|
FISCAL
|
|
SALARY
|
|
BONUS
|
|
STOCK AWARDS
|
|
ALL OTHER COMPENSATION
|
|
TOTAL
|
POSITION
|
|
|
YEAR
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antonio Domingues (1)
|
|
|
2013
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
President, Chief Financial Officer, Treasurer and Director
|
|
|
2012
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ruy Cabrera (2)
|
|
|
2013
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
Chief Executive Officer, President, Chief Financial Officer, Treasurer, Secretary and Director
|
|
|
2012
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
(1) Mr. Domingues served as our
President, Treasurer and Chief Financial Officer from April 3, 2012 until May 9, 2013.
(2) Mr. Cabrera served as our Chief Executive
Officer, President, Chief Financial Officer, Treasurer and Secretary from May 8, 2013 until February 6, 2014.
Director Compensation
The following table shows information regarding
the compensation earned during the fiscal year ended June 30, 2013 and 2012 by members of our Board of Directors.
|
|
Fees
|
Stock Options
|
|
Non-Equity
Incentive
|
Non-qualified
Deferred Comp
|
All other
|
Total
|
Antonio Domingues (1)
|
2013
2012
|
—
—
|
—
—
|
|
—
—
|
—
—
|
—
—
|
—
—
|
Jeffrey Leuchter (2)
|
2013
2012
|
—
—
|
—
—
|
|
—
—
|
—
—
|
—
—
|
—
—
|
(1)
|
Mr. Domingues served as a member of our Board of Directors and an executive officer from April 3, 2012 until May 9, 2013.
|
(2)
|
Mr. Leuchter served as a member of our Board of Directors and an executive officer from May 8, 2013 until February 11, 2014.
|
INCENTIVE PLANS
We have not adopted a stock incentive or similar
plan.
PENSION BENEFITS
There were no pension benefit plans in effect
in our 2013 or 2012 fiscal years.
NONQUALIFIED DEFINED CONTRIBUTION AND OTHER
NONQUALIFIED DEFERRED COMPENSATION PLANS
There were no nonqualified defined contributions
or other nonqualified deferred compensation plans in effect in 2013 or 2012 fiscal years.
OPTION GRANTS IN LAST FISCAL YEAR
We did not grant to the Named Executive Officer,
or any other person options to purchase shares in fiscal 2013 or 2012.
AGGREGATED OPTION EXERCISES IN LAST FISCAL
YEAR AND FISCAL YEAR-END OPTION VALUES
None of our officers held options to purchase
shares of our Common Stock during fiscal 2013 or 2012.
EMPLOYMENT AGREEMENTS
We have not entered into employment agreements
with any person.
DIRECTOR COMPENSATION
We have not compensated our Board members for
their participation on the Board and do not have any standard or other arrangements for compensating them for such services. We
may issue shares of our Common Stock or options to acquire shares of our Common Stock to members of our Board of Directors in consideration
for their services as members of our Board of Directors. We may also reimburse Directors for expenses incurred in connection
with their attendance at meetings of the Board of Directors.
Involvement in Certain Legal Proceedings
There have been no events under any bankruptcy
act, no criminal proceedings and no judgments, injunctions, orders or decrees material to the evaluation of the ability and integrity
of any director, executive officer, promoter or control person of the Company during the past five years.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT
Beneficial Ownership Information as of June 2, 2014
The following table sets forth information
regarding the beneficial ownership of the shares of our Common Stock as of May 20, 2014 by:
|
-
|
Each person whom we know to be the beneficial owner of 5% or more of our outstanding Common Stock;
|
|
-
|
Each of our executive officers;
|
|
-
|
Each of our directors; and
|
|
-
|
All of our executive officers and directors as a group.
|
As of June 2, 2013, 195,480,000 shares
of our Common Stock were issued and outstanding. Unless otherwise indicated in the table, the persons and entities named in
the table have sole voting and sole investment power with respect to the shares set forth opposite the stockholder’s
name, subject to community property laws, where applicable. Beneficial ownership is determined in accordance with the rules
of the SEC. The address of each stockholder is listed in the table. There are no shares of any other class or
series of stock issued and outstanding.
Name and Address of Beneficial Owner
|
|
Amount and Nature of Beneficial Owner
|
|
Percentage of Class
|
|
|
|
|
|
Mohamed K. Karatella
140 Shorting Road
Toronto, ONT M1S 356
|
|
130,000,000
|
|
66.5%
|
Kenneth Pinckard
350 Bay St. Suite 1300
Toronto On M5H 2S6
Chief Executive Officer
|
|
0
|
|
0%
|
Preston J. Shea
350 Bay St. Suite 1300
Toronto On M5H 2S6
|
|
0
|
|
0%
|
|
|
|
|
|
All directors and executive officers as a group (2 persons):
|
|
0
|
|
0%
|
ITEM. 13 CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS
We have not entered into transactions with
our officers, Directors, persons nominated for these positions, beneficial owners of 5% or more of our Common Stock or family members
of these persons wherein the amount involved exceeds the lesser of $120,000 or one percent company's total assets at year end for
the last completed fiscal year.
We did not have any promoters besides our directors
at any time during the past five fiscal years.
In November 2013, the company paid a Company
owned by Mr. Karatella, $19,093 for services rendered to and expenses incurred on behalf of the Company during 2011 and 2012 and
in November 2013, paid to Mr. Karatella $4,773 for services rendered to the Company during 2011 and 2012
and expenses incurred on behalf of the Company.
Review, approval or ratification of transactions
with related persons
Currently, we do not have formal policies
and procedures for the review, approval, or ratification of transactions with related persons. However, our board carefully
reviews all transactions between the Company and related persons to determine whether the relationship is in the best interest
of the Company and that the terms of any agreement are no less favorable to the Company then they would be if the relationship
was with an unrelated third party.
Our Board of Directors currently consists of
two (2) directors. The Company is not a listed issuer whose securities are listed on a national securities exchange, or an inter-dealer
quotation system which has requirements that a majority of the board of directors be independent. Under NASDAQ Rule 5605(a) (2)
(A), a director is not considered to be independent if he or she also is an executive officer or employee of the corporation. Under
such definition, our directors, Kenneth Pinckard and Preston J. Shea, would not be considered independent as each also serves as
either an executive officer or employee of the Company. Presently we are not required to comply with the director independence
requirements of any national securities exchange. Prior to having our securities listed on any national securities exchange,
we would appoint directors that meet the independence requirements of the applicable exchange.
Compensation Policies and Practices as They
Relate to Risk Management
The Company does not currently believe that
any risks arising from its compensation policies and practices for its employees are reasonably likely to have a material adverse
effect on the Company. As of the date of this Report, however, the Company has not completed the process of evaluating its compensation
policies and practices as they relate to the Company’s risk management. Upon completion of this evaluation, the Company’s
assessment of the potential effects of risks arising from its compensation policies may change.
The following exhibits are included with this
filing:
Exhibit Number
|
|
Description
|
|
|
|
|
|
|
|
|
|
3.1
|
|
Articles of Incorporation**
|
|
3.2
|
|
Bylaws**
|
|
3.3
|
|
Certificate of Amendment to Articles of Incorporation***
|
|
10.2
|
|
Share Purchase Agreement dated August 4, 2011 between MDRM Group (Canada) Ltd. (of the first part), Michalkoff Family Trust, Hrycyshyn Family Trust and Stolarchuk Family Trust (of the second part), Lumigene Technologies Inc. (of the third part) and Mark Michalkoff, Roman Hrycyshyn and Danylo Stolarchuk (of the fourth part). ****
|
|
23.1
|
|
Consent of
Ronald R. Chadwick, P.C.
|
|
31
|
|
Sec. 302 Certification of CEO/CFO*
|
|
32
|
|
Sec. 906 Certification of CEO/CFO*
|
|
*
|
Filed herewith.
|
**
|
Included in our S-1 filing on August 23, 2010.
|
***
|
Included in our current report on Form 8-K filed with the Securities and Exchange Commission on August 18, 2011.
|
****
|
Included in our current report on Form 8-K filed with the Securities and Exchange Commission on August 10, 2011.
|
Item
14. Principal Accountant Fees and Services
Our Board of Directors was directly responsible
for interviewing and retaining our independent accountant, considering the accounting firm's independence and effectiveness, and
pre-approving the engagement fees and other compensation to be paid to, and the services to be conducted by, the independent accountant.
Our Board did not delegate these responsibilities. During our
2013 and 2012 fiscal years, our Board
of Directors pre-approved 100% of the services described below.
The
total fees charged to the company for audit services, including interim reviews by
Cutler
& Co., LLC were $______, for audit-related services were $Nil, for tax services were $Nil and for other services were $Nil
during the year ended June 30, 2013.
The total fees charged to the company for audit
services, including interim reviews by Ronald R. Chadwick, P.C. were $______, for audit-related services were $Nil, for tax services
were $Nil and for other services were $Nil during the year ended June 30, 2013.
For the year ended June 30, 2012, the total
fees charged to the company for audit services by Ronald R. Chadwick, P.C., including interim reviews was $6,700, for audit-related
services were $Nil, for tax services were $Nil and for other services were $Nil.
The accompanying notes are an integral part
of these audited consolidated financial statements.
NOTES TO AUDITED CONSOLIDATED FINANCIAL
STATEMENTS
FOR THE TWELVE MONTHS ENDED JUNE 30,
2013 AND 2012 AND FROM DECEMBER 19, 2007 (INCEPTION) TO JUNE 30, 2013
1.
Nature of Operations and Summary of Significant Accounting Policies
Nature of Operations
Modern Mobility Aids, Inc. (the “Company”)
was incorporated under the laws of the State of Nevada on December 19, 2007 (Inception) under the name Glider Inc. with a business
plan to sell and distribute products for mobility challenged individuals. The Company changed its name to Modern Mobility Aids,
Inc. on April 22, 2010 with an initial plan to distribute products for mobility challenged individuals.
In May of 2011, the business focus of
the Company evolved with a rapid expansion strategy in the life sciences and healthcare industry. A mandate was created to acquire companies
within the biopharma sector, targeting innovative research and development as well as scalable manufacturing capacity in three
niche market segments:
1.
CRAM – Contract Research and Manufacturing for Life Sciences Companies
2.
HEALTHCARE INNOVATION – Novel Drug and Device Delivery Format Packaging
3.
BIOPHARMA PARTNERSHIPS – Strategic Development and Production Alliances
The Company has abandoned its historic
business which has generated little operating revenue and has had limited operations to date. Its Board of Directors has determined
that the Company will seek to acquire business assets or stock in companies that either have existing operations or are in the
development stage with the potential for successful operations.
During the period from December 19, 2007,
through June 30, 2013, the Company was organized and incorporated, conducted a capital formation activity to raise $47,425 through
the issuance of 195,480,000 (post forward split) shares of common stock, and realized $9,506 in revenues from sales.
During the year ended June 30, 2011,
the Company’s Registration Statement on the Form S-1/A filed with the Securities and Exchange Commission was declared effective.
The Company sold 65,480,000 (post forward split) common shares at $0.0125 per share for total proceeds of $40,925 pursuant to this
Registration Statement. Company intends to conduct additional capital formation activities through the issuance of its common stock
and to further conduct its operations.
The Company has abandoned its historic
business which has generated little operating revenue and has had limited operations to date. Its Board of Directors has determined
that the Company will seek to acquire business assets or stock in companies that either have existing operations or are in the
development stage with the potential
for successful operations. The Company
will require financing to make such acquisitions. There can be no assurance it can secure such financing or that it will be able
to make such acquisitions even if financing is available. Moreover, even if it acquires business assets or a business, there can
be no assurance that the acquisitions will be successfully accomplished and that our operations thereafter will be profitable.
While management of the Company believes
that the Company will be successful in its planned operating activities under its business plan and capital formation activities,
there can be no assurance that it will be successful in implementation of its business plan or the formation of sufficient capital
such that it will generate adequate revenues to earn a profit or sustain its operations.
MODERN MOBILITY AIDS, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO AUDITED CONSOLIDATED FINANCIAL
STATEMENTS
FOR THE TWELVE MONTHS ENDED JUNE 30,
2013 AND 2012 AND FROM DECEMBER 19, 2007 (INCEPTION) TO JUNE 30, 2013
1.
Nature of Operations and Summary of Significant Accounting Policies
Cont.
Development
Stage Company
The Company is a development stage company
in accordance with Financial Accounting Standards Codification (“ASC”) 915 "Development Stage Entities".
Among the disclosures required as a development stage company are that our financial statements are identified as those of a development
stage company, and that the statements of operations, changes in stockholders' deficit and cash flows disclose activity since the
date of our Inception (December 19, 2007) as a development stage company.
Principles
of Consolidation
The Company's consolidated financial
statements for the year ended June 30, 2013, include the accounts of its wholly owned subsidiaries Modern Mobility Aids, Inc.,
an Ontario, Canada, based company and MDRM Group (Canada) Ltd. an Ontario, Canada based company. Modern Mobility Aids, Inc. was
incorporated on September 2, 2009, during the year ended June 30, 2011. MDRM Group (Canada) Ltd. was incorporated on July 14, 2011.
All significant intercompany balances and transactions have been eliminated on consolidation.
Cash and Cash Equivalents
For purposes of reporting within the statements of cash flows,
the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid
debt instruments purchased with a maturity of three months or less to be cash and cash equivalents.
Revenue Recognition
The
Company is in the development stage and has realized minimal revenues from operations. The Company recognizes revenues when the
sale and/or distribution of products is complete, risk of loss and title to the products have transferred to the customer, there
is persuasive evidence of an agreement, acceptance has been approved by its customer, the fee is fixed or determinable based on
the completion of stated terms and conditions, and collection of any related receivable is probable. Net revenues are comprised
of gross revenues less expected returns, trade discounts, and customer allowances that include costs associated with off-invoice
markdowns and other price reductions, as well as trade promotions and coupons. These incentive costs are recognized at the later
of the date on which the Company recognized the related revenue or the date on which the Company offers the incentive.
Loss per Common Share
Basic loss per share is computed by dividing
the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during
the periods. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include
the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the
additional common shares were dilutive. There were no dilutive financial instruments issued or outstanding for the years ended
June 30, 2013 and 2012 and for the period from inception (December 19, 2007) through June 30, 2013.
MODERN MOBILITY AIDS, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO AUDITED CONSOLIDATED FINANCIAL
STATEMENTS
FOR THE TWELVE MONTHS ENDED JUNE 30,
2013 AND 2012 AND FROM DECEMBER 19, 2007 (INCEPTION) TO JUNE 30, 2013
1. Nature of Operations and Summary of Significant
Accounting Policies Cont.
Income Taxes
The Company accounts for income taxes
pursuant to SFAS No. 109,
“Accounting for Income Taxes”
(“SFAS No. 109”). Under SFAS No. 109, now
encompassed under ASC 740,
deferred tax assets and liabilities are determined based on temporary
differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax
assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating
the differences.
The Company maintains a valuation allowance
with respect to deferred tax assets. Modern Mobility Aids establishes a valuation allowance based upon the potential likelihood
of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations
for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within
the carryforward period under the Federal tax laws.
Changes in circumstances, such as the
Company generating taxable income, could cause a change in judgment as to whether the related deferred tax asset could be realized.
Any change in the valuation allowance will be included in income in the year of the change in estimate.
Fair Value of Financial Instruments
The Company estimates the fair value
of financial instruments using the available market information and valuation methods. Considerable judgment is required in estimating
fair value. Accordingly, the estimates of fair value may not be indicative of the amounts Modern Mobility Aids could realize in
a current market exchange. As of June 30, 2013, the carrying value of the Company’s financial instruments approximated fair
value due to the short-term nature and maturity of these instruments.
Deferred Offering Costs
The Company defers as other assets the
direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the
offering, the costs are charged against the capital raised. Should the offering be terminated, deferred offering costs are charged
to operations during the period in which the offering is terminated.
Impairment of Long-lived Assets
Capital assets are reviewed for impairment
in accordance with SFAS No. 144,
“Accounting for the Impairment of Disposal of Long-lived Assets,”
which was
adopted effective January 1, 2002. Under SFAS No. 144,
now encompassed under ASC 350,
these assets are tested for recoverability whenever events or changes in circumstances indicate that their carrying amounts
may not be recoverable. An impairment charge is recognized for the amount, if any, which the carrying value of the asset exceeds
the fair value. For the year ended June 30, 2013, and 2012 and for the period from inception (December 19, 2007) through June 30,
2013, no events or circumstances occurred for which an evaluation of the recoverability of long-lived assets was required.
MODERN MOBILITY AIDS, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO AUDITED CONSOLIDATED FINANCIAL
STATEMENTS
FOR THE TWELVE MONTHS ENDED JUNE 30,
2013 AND 2012 AND FROM DECEMBER 19, 2007 (INCEPTION) TO JUNE 30, 2013
1. Nature of Operations and Summary of Significant
Accounting Policies Cont.
Advertising and Promotion
The
Company expenses all advertising and promotion costs as incurred. The Company did not incur advertising and promotion costs during
the years ended June 30, 2013, and 2012.
Stock-based Compensation
The Company
accounts for employee and non-employee stock awards under ASC 718, whereby equity instruments issued to employees for services
are recorded based on the fair value of the instrument issued and those issued to non-employees are recorded based on the fair
value of the consideration received or the fair value of the equity instrument, whichever is more reliably measurable.
Foreign Currency Transactions
Foreign
currency transaction gains and losses are recorded in the statements of operations as a component of other income (expense
).
Use of Estimates and Assumptions
The accompanying financial statements
of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America.
Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements
for a period necessarily involves the use of estimates which have been made using careful judgment. Actual results may vary from
these estimates.
Reclassifications
Certain
amounts previously presented for prior periods have been reclassified. The reclassifications had no effect on net loss, total assets,
or total shareholders’ deficit.
Recently Adopted Accounting Pronouncements
Management
does not believe that any recently issued, but not yet effective, accounting standards, if adopted, will have a material effect
on our financial statements.
MODERN MOBILITY AIDS, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO AUDITED CONSOLIDATED FINANCIAL
STATEMENTS
FOR THE TWELVE MONTHS ENDED JUNE 30,
2013 AND 2012 AND FROM DECEMBER 19, 2007 (INCEPTION) TO JUNE 30, 2013
2.
Going Concern
The accompanying financial statements
have been prepared in conformity with accounting principles generally accepted in the United State of America, which contemplate
continuation of the Company as a going concern. The Company has not established a source of revenues sufficient to cover its operating
costs, and as such, has incurred an operating loss since inception. Further, as of June 30, 2013, and June 30, 2012, the Company
had a working capital deficiency of $(516,670), and $(467,171), respectively. These and other factors raise substantial doubt about
the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments
or classifications that may result from the possible inability of the Company to continue as a going concern.
The Company will seek to acquire business
assets or stock in companies that either have existing operations or are in the development stage with the potential for successful
operations. The Company will require financing to make such acquisitions. There can be no assurance it can secure such financing
or that it will be able to make such acquisitions even if financing is available. Moreover, even if it acquires business assets
or a business, there can be no assurance that the acquisitions will be successfully accomplished and that our operations thereafter
will be profitable.
While management of the Company believes
that the Company will be successful in its planned operating activities under its business plan and capital formation activities,
there can be no assurance that it will be successful in implementation of its business plan or the formation of sufficient capital
such that it will generate adequate revenues to earn a profit or sustain its operations.
3.
Shareholder Deficit
The total
number of common shares authorized that may be issued by the Company is 200,000,000 shares with a par value of $0.001 per share,
and 1,000,000 shares of preferred stock at par value of $0.001 per share.
During the year ended June 30, 2010,
the Company issued 130,000,000 shares of common stock to its Directors for total proceeds of $6,500.
During the year ended June 30, 2011 the
Company sold 65,480,000 common shares for total proceeds of $58,767.
On August 18, 2011, the Company implemented
a 20 for 1 forward stock split whereby each shareholder of record received an additional 19 shares of common stock for every 1
share held of record. The total number of common stock issued and outstanding as of June 30, 2013 was amended for this forward
stock split. All references to shares reflect the split.
As of June 30, 2013, the Company had
not issued any shares nor granted any stock options under share-based compensation transactions.
As at June 30, 2013 there were 195,480,000
shares of common stock issued and outstanding.
MODERN MOBILITY AIDS, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO AUDITED CONSOLIDATED FINANCIAL
STATEMENTS
FOR THE TWELVE MONTHS ENDED JUNE 30,
2013 AND 2012 AND FROM DECEMBER 19, 2007 (INCEPTION) TO JUNE 30, 2013
4.
Income Taxes
The
provision (benefit) for income taxes for the year ended June 30, 2013 and June 30, 2012, were as follows (assuming a 15 percent
effective tax rate):
|
|
|
|
|
Year Ended
|
|
|
|
|
|
June 30,
|
|
|
|
|
|
2013
|
|
|
2012
|
|
|
|
|
|
|
|
|
|
Current Tax Provision:
|
|
|
|
|
|
|
|
Federal
|
|
|
|
|
|
|
|
|
Taxable income
|
|
$
|
-
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
Total current tax provision
|
$
|
-
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
Deferred Tax Provision:
|
|
|
|
|
|
|
|
Federal
|
|
|
|
|
|
|
|
|
Loss carryforwards
|
$
|
8,282
|
|
$
|
54,542
|
|
Change in valuation allowance
|
$
|
(8,282)
|
|
$
|
(54,542)
|
|
|
|
|
|
|
|
|
|
|
Total deferred tax provision
|
$
|
-
|
|
$
|
-
|
The Company had deferred income tax assets as of June 30,
2013 and June 30, 2012 as follows:
|
|
|
|
Year Ended
|
|
|
|
|
June 30,
|
|
|
|
|
2013
|
|
|
2012
|
|
|
|
|
|
|
|
|
Loss carryforwards
|
$
|
585,040
|
|
$
|
532,438
|
Less - Valuation allowance
|
|
(585,040)
|
|
|
(532,438)
|
|
|
|
|
|
|
|
|
Total net deferred tax assets
|
$
|
-
|
|
$
|
-
|
As of June 30, 2013, the Company had approximately $585,040
in tax loss carry forwards that can be utilized in future periods to reduce taxable income, and begin to expire in the year 2028.
The Company provided a valuation allowance
equal to the deferred income tax assets for the year ended June 30, 2013 and June 30, 2012 because it is not presently known whether
future taxable income will be sufficient to utilize the loss carry forwards.
5.
Shareholder Loans
The loans payable to shareholders are
payable on demand, unsecured and bears no interest. The loan shall be payable on demand within five (5) days from the date of request.
In the event payment is not timely made, interest will accrue on the unpaid balance at the rate of 15% per annum, compounded monthly,
from and after the date of such failure to pay. As of June 30, 2013, the loan consisted of $360,567 principal and accrued interest
of $Nil.
MODERN MOBILITY AIDS, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO AUDITED CONSOLIDATED FINANCIAL
STATEMENTS
FOR THE TWELVE MONTHS ENDED JUNE 30,
2013 AND 2012 AND FROM DECEMBER 19, 2007 (INCEPTION) TO JUNE 30, 2013
6.
Related Party Transactions
As of the balance sheet date there
was an account payable balance to related parties in the amount of $19,179 for services provided to the Company.
In November 2013, the company paid
a Company owned by Mr. Karatella, $19,093 for services rendered to and expenses incurred on behalf of the Company during
2011 and 2012 and in November 2013, paid to Mr. Karatella $4,773 for services rendered to the Company during 2011 and 2012 and
expenses incurred on behalf of the Company.
7.
Subsequent
Events
Mohamed
K. Karatella, formerly the Company’s President, Chief Financial Officer, Treasurer, Principal Accounting Officer and the
owner of 66.5% of its outstanding common stock has agreed to contribute 120,000,000 shares of the Company’s common stock
to the Company to be cancelled. Mr. Karatella will not receive any compensation in connection with this transfer. After the transaction,
Mr. Karatella will own 10,000,000, 13.25%, of 75,480,000 shares of common stock of the Company then outstanding.
On March 28, 2014, through a wholly-owned
subsidiary incorporated under the laws of Ontario, Canada, we entered into a Memorandum of Understanding to purchase 67% of a
private company with a pending application for a license from Health Canada under the recently enacted Marijuana for Medical Purposes
Regulation (“MMPR”). The facilities are located in the Province of Ontario. In addition, the agreement provides that
we will also acquire a 50% interest in a related private corporation which has received a “ready to build” letter
from Health Canada in conjunction with a pending application for a license to conduct research on marijuana. The closing of this
transaction is contingent on the issuance of the respective licenses by Health Canada.
On May 8, 2014, through a wholly-owned
subsidiary formed in Ontario, Canada, we entered into an agreement to purchase 100% of a private company in the final stage of
obtaining their Medical Marijuana growers license. The company, located in the Province of Ontario, owns a fully functional production
facility, and is awaiting final inspection by Health Canada. The transaction includes real property and related facilities.
Under the terms of the agreement, the
company will pay CDN$2.5 million at Closing with an additional CDN$2.5 million due at a deferred date. The company will also issue
a warrant to the sellers to purchase up to 1 million shares of the Company shares at a 25% discount to market. The closing of the
purchase is subject to receipt of a license from Health Canada under MMPR.
The
Company is actively and aggressively pursuing various other opportunities relating to the medical marijuana and biopharma industries
which meet its investment criteria. To this end, we have entered into letters of intent to purchase controlling interests in two
other private companies each in the final stages of obtaining their Medical Marijuana growers license. The actual terms and conditions
of these two proposed transactions will be disclosed at such time as the Company has entered into definitive agreements on the
matters.
In accordance with ASC 855, Subsequent Events,
the Company has evaluated events that occurred subsequent to the balance sheet date through May 20, 2014, the date of available
issuance of these audited financial statements. The Company determined that other than as disclosed above, there were no material
reportable subsequent events to be disclosed.